7/103 sources · 3 publishersUpdated Oct 8, 21:38 UTC
NeoGenomics announces CEO transition and reports preliminary Q3 revenue of about $209 million
NeoGenomics said President and COO Warren Stone will become CEO on January 4, 2027, with current CEO Tony Zook moving to Executive Chairman. The company posted unaudited third‑quarter 2026 revenue of approximately $209 million, beating the consensus estimate of $205.89 million. Shares fell 3.6% after the announcement, while the firm kept its full‑year revenue and adjusted EBITDA guidance unchanged.
Why it matters
The stock slipped 3.6% on the news, reflecting investor concern over the leadership change without an upgrade to guidance. The unchanged guidance means investors should not expect near‑term revenue revisions beyond the Q3 beat.
Key facts
- 1Preliminary unaudited third‑quarter revenue was approximately $209 million. investing.com
- 2Shares fell 3.6% in after‑hours trading following the announcement. investing.com
- 3Warren Stone will become CEO effective January 4, 2027. investing.com
- 4Consensus analyst estimate for Q3 revenue was $205.89 million. investing.com
- 5Next‑generation sequencing revenue grew about 28% year‑over‑year. investing.com
- 6Lynn Tetrault will step down as Chair effective January 4, 2027. investing.com
Summary written by AlphAI from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.